US 8497295
Spiroindoline modulators of muscarinic receptors
granted A61KA61K31/435A61K31/438
Quick answer
US patent 8497295 (Spiroindoline modulators of muscarinic receptors) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/435, A61K31/438, A61K31/4747, A61K31/55